Related Experiment Videos
Early Vascular Ageing (EVA): Definitions and Clinical Applicability
Pedro Guimaraes Cunha1, Pierre Boutouyrie2, Peter M Nilsson3
1Center for the Research and Treatment of Arterial Hypertension and Cardiovascular Risk - Internal Medicine Department, Guimaraes Guimaraes, Portugal.
Current Hypertension Reviews
|April 18, 2017
Summary
Early Vascular Ageing (EVA) identifies accelerated arterial ageing, a cardiovascular disease risk marker. Understanding EVA
Area of Science:
- Cardiovascular Science
- Vascular Biology
- Gerontology
Background:
- Arterial stiffness is a recognized intermediate cardiovascular endpoint and an independent risk marker for cardiovascular disease.
- It signifies a dissociation between chronological and biological age of large arteries, leading to premature cardiovascular risk.
- This process reflects accelerated vascular ageing, distinct from normal ageing patterns.
Purpose of the Study:
- To introduce and elaborate on the concept of Early Vascular Ageing (EVA).
- To highlight EVA's role in primordial prevention of cardiovascular disease.
- To explore the underlying pathophysiology, consequences, and therapeutic strategies related to accelerated vascular ageing.
Main Methods:
- The study conceptualizes Early Vascular Ageing (EVA) based on existing evidence.
- It involves identifying individuals with accelerated ageing paths.
- Focuses on inherent features, environmental interactions, and arterial insults leading to medial layer changes.
Main Results:
- Early Vascular Ageing (EVA) is proposed as a construct to identify individuals with accelerated arterial ageing.
- This accelerated ageing is linked to increased cardiovascular risk.
- Medial layer morphological changes are identified as a consequence of various insults.
Conclusions:
- Understanding the pathophysiology of vascular ageing and EVA is crucial for effective prevention.
- Translating the EVA construct into clinical practice can improve cardiovascular disease prevention and survival.
- Further research into EVA is needed to refine its clinical application.